PhD in Machine Learning and Computational Chemistry for Binding Affinity Prediction
Doctoral student position in
machine learning and computational chemistry
at
Lund University
, in collaboration with
AstraZeneca
and
Uppsala University
.
The project focuses on
binding affinity prediction
for small molecules in drug design, combining physics-based methods and modern machine learning. Research topics include
MM/PBSA
,
free-energy perturbation
,
SQM 2.20
,
fragment molecular orbital calculations
, molecular modelling, quantum mechanics, statistical mechanics, and data-driven model development for prioritising drug candidates from hit discovery to lead optimisation.
The host environment is the
Division of Computational Chemistry
and the
Computational Biochemistry group
, which works across quantum chemistry, statistical mechanics, machine learning, biochemistry, medicinal chemistry, and structural biology. The project is tightly linked to Molecular AI at AstraZeneca and the Department of Pharmaceutical Biosciences at Uppsala University.
Eligibility highlights: applicants should have an MSc in computational chemistry, bioinformatics, machine learning, computer science, mathematics, statistics, physics, or a related discipline. Required skills include Python/programming, independent research ability, strong communication skills, good English, and a collaborative mindset. Preferred experience includes machine learning for scientific problems, molecular dynamics, molecular mechanics, quantum mechanics, binding affinity prediction, HPC, workflow tools, automation, and collaborative software development.
This is a
full-time fixed-term doctoral studentship
starting
2026-09-01
or as agreed. The employment is for 4 years full time, with extension possible for teaching and departmental duties. The post is based in
Lund, Sweden
.
Application materials must be in English and include a CV, cover letter, degree/study certificates, and any additional supporting documents such as transcripts, references, or recommendation letters. Deadline:
2026-04-26
.